COMPANY INTELLIGENCEWhat the linked records show
MedtechLedger currently links 23 FDA records to the applicant name ZOLL MEDICAL CORPORATION. It includes 2 original PMA approvals. 14 entries are PMA supplements. 7 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from May 26, 2017 to Oct 16, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MKJ appears in 21 of the 23 linked filings. The collection spans 3 FDA product codes and 5 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P160022, with 13 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 4 linked filings have a current plain-language explanation checked against the recorded FDA decision.
Applicant mailing address recorded by FDA: 269 & 271 Mill Rd., Chelsmford, MA, 01824. Recorded on P160015/S029, decision dated Oct 16, 2026.
Device categories in this collection
Automated External Defibrillators (Non-Wearable); Combination compression/decompression manual chest pump with impedance respiratory valve; Ventilator, High Frequency.
Changes described in PMA records
FDA's database lists P160015/S029 for ZOLL Medical Corporation's AED 3 Defibrillator with Uni-Padz as a normal 180-day-track PMA supplement without user fee, approved 2026-10-16. The supplement reason is postapproval study protocol, and the statement describes approval of a protocol for the post-approval study to replace the original PAS protocol.
Because S029 is a supplement to P160015, it modifies an element of that existing approval rather than approving the device system anew. The statement says the submitted PAS protocol complies with conditions of approval in the P160015/S001 order. It does not report PAS results, so it is not evidence of safety or clinical effectiveness; the replacement protocol's design, endpoints and timeline are absent.
FDA approval-order wording
approval of the protocol for the post-approval study (PAS) referenced above to replace the original PAS protocol. The PAS protocol has been submitted to comply with the conditions of approval outlined in the approval order for P160015/S001.
Oct 16, 2026 · Normal 180 Day Track No User FeeThe FDA recorded decision OK30 on 2026-10-16 for PMA supplement P160022/S056, submitted by ZOLL Medical Corporation for the ZOLL R Series Monitor/Defibrillator. The supplement is filed as a 30-Day Notice with a recorded reason of process change affecting manufacturer, sterilizer, packager or supplier. The listed device category is automated external defibrillators (non-wearable), specialty Cardiovascular, product code MKJ.
The recorded statement describes an alternate critical component on the printed circuit board assembly. That scope concerns a component-level change within the existing PMA, not a new approval of the whole monitor/defibrillator system. The source record does not identify the specific component, the supplier, or the basis for the decision, and no supporting documents are listed, so the technical and clinical significance of the substitution cannot be assessed from this data alone.
FDA approval-order wording
an alternate critical component on the printed circuit board assembly
Oct 16, 2026 · 30-Day NoticeZOLL Medical Corporation filed a 30-Day Notice, supplement S054 to PMA P160022, recorded with decision OK30 on 2026-10-02. The database lists the change as "an alternate electrode manufacturing line" under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The named device grouping covers X Series, R Series, AED Pro and AED 3 BLS professional defibrillators, the Pro-Padz Radiotransparent Electrode and SurePower, within the non-wearable automated external defibrillator category (product code MKJ).
The S054 identifier frames this as a supplement to the existing PMA rather than an original approval, and a manufacturing notice does not constitute approval of the whole system. The database field does not identify which electrode or component the alternate line produces, its location, qualification data, or any FDA review finding beyond the stated decision code; the notice's purpose should not be read as independent evidence of safety or clinical effectiveness. Whether the alternate line applies to Pro-Padz, another electrode, or the defibrillator units themselves is absent.
FDA approval-order wording
an alternate electrode manufacturing line
Oct 2, 2026 · 30-Day NoticeFDA’s recorded scope: a component supplier manufacturing site change for the Timing Assist Light Board
Aug 27, 2026 · 30-Day NoticeFDA’s recorded scope: approval of the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in the approval order for P160015/S001.
Jul 16, 2026 · Normal 180 Day Track No User FeeSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.